Osamu Nureki
Vermogen: 447 002 $ op 31-05-2026
Vermogen: 447 002 $ op 31-05-2026
Osamu Nureki is the founder of Modalis Therapeutics Corp., which was founded in 2016.
He holds the title of Outside Director at the company.
He is currently working as an Outside Director at Curreio, Inc. since 2019 and as a Professor at the University of Tokyo since 2008.
Dr. Nureki completed his undergraduate and graduate degrees at the University of Tokyo.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 1.581.300 ( 1,64% ) | 447 002 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Oprichter | 01-01-2016 |
Curreio, Inc.
Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Directeur/Bestuurslid | 01-11-2019 |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-04-2008 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modalis Therapeutics Corp.
Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Curreio, Inc.
Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau